A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...

56% Increase in C. diff Due in Part to Improved Detection Hospitals that switched Clostridium difficile testing from nonmolecular to molecular methods recorded a 56 percent increase in recorded C.

Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.

Arlington, Va., May 11, 2023 – A new study published today in the American Journal of Infection Control (AJIC) suggests that allowing bedside nurses to independently order testing for C. difficile ...

A new study published today in the American Journal of Infection Control (AJIC) suggests that allowing bedside nurses to independently order testing for C. difficile significantly decreased the amount ...

After piloting new Clostridioides difficile guidelines for nine months, Memorial Healthcare System reduced unnecessary treatments by 20.1%, according to a study published June 27 in the American ...

The CDC provides a free online video for healthcare providers on testing for Clostridium difficile. In the video, Dr. Carolyn Gould, a medical epidemiologist in the Division of Healthcare Quality ...

C. diff infection can cause diarrhea. While it may lead your poop to change color, there are no specific colors that are definitive evidence of having C. diff. According to the Centers for Disease ...

Finch Therapeutics' phase 3 trial for a Clostridioides difficile med has been placed on clinical hold by the FDA as the agency requests more information on how the biotech screens the donor-derived ...

After the first year of interventions at Emory Saint Joseph's Hospital, there was a 63% decrease in hospital-onset C. diff cases as compared to the two years prior. Through a series of interventions ...

BOULDER, CO, UNITED STATES, October 8, 2025 /EINPresswire.com/ -- Faex Health, a fast-growing digital health startup, today announced the release of its C. difficile ...

Please provide your email address to receive an email when new articles are posted on . More patients in the bezlotoxumab group experienced recurrence vs. the placebo group (13% vs. 3%). Steroid use ...